Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane versus anastrozole in postmenopausal women with receptor-positive primary breast cancer
2005-001893-28Phase 3Completed
- Sponsor
- International Breast Cancer Study Group
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Exemestane arm with Anastrozole arm (2 arms). Primary endpoint: Event-free survival. Started Oct 2005; status: completed.
02
Drugs
exemestaneanastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-001893-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001893-28.